Jim Miller predicts in his column in this month's Pharmaceutical Technology that big pharma will become an increasing competitor to CMO's in 2010 with at least one more big player, in addition to companies like Pfizer or Abbott, selling its excess commercial manufacturing capacity - including biologics manufacturing. See full article for other predictions.
Posted by Bruce Lehr Jan 21, 2010
Comments